Icheva, V. D., Kayser, S. E. M., Wolff, D., Tuve, S., Kyzirakos, C., Bethge, W. A., . . . Feuchtinger, T. F. (2013). Adoptive transfer of Epstein-Barr Virus (EBV) nuclear antigen 1-specific T cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. Journal of clinical oncology, 31(1), . https://doi.org/10.1200/JCO.2011.39.8495
Chicago Style (17th ed.) CitationIcheva, Vanya Dimitrova, et al. "Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1-specific T Cells as Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-cell Transplantation." Journal of Clinical Oncology 31, no. 1 (2013). https://doi.org/10.1200/JCO.2011.39.8495.
MLA (9th ed.) CitationIcheva, Vanya Dimitrova, et al. "Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1-specific T Cells as Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-cell Transplantation." Journal of Clinical Oncology, vol. 31, no. 1, 2013, https://doi.org/10.1200/JCO.2011.39.8495.